Skip to main content
Epocrates Online
Contact us
Explore features
Reach clinicians
Buy now
By
vgreene
, 8 March, 2019
Tx experienced on 1 drugs not at A1C target
By
vgreene
, 8 March, 2019
On mono tx A1C not at target
By
vgreene
, 8 March, 2019
No ASCVD or high risk of HF or CKD
By
vgreene
, 8 March, 2019
Tx-experienced (on ≥1 drugs), not at HbA1c target
By
vgreene
, 8 March, 2019
On dual or triple tx, HbA1c not at target
By
vgreene
, 8 March, 2019
Established HF or CKD
By
vgreene
, 8 March, 2019
Established ASCVD
By
vgreene
, 8 March, 2019
No established ASCVD, HF, or CKD
By
vgreene
, 8 March, 2019
On mono-tx, HbA1c not at target
By
vgreene
, 7 March, 2019
Urinary Tract Sx, Lower/BPH
Pagination
First page
Previous page
…
Page
2449
Page
2450
Page
2451
Page
2452
Current page
2453
Page
2454
Page
2455
Page
2456
Page
2457
…
Next page
Last page
About Us
Company Overview
Media Relations
Contact
Editorial Policy
Editorial Process
Third-Party Sponsorship Policy
athenahealth
Products
Core Products
Mobile CME
Product Licenses
Business Solutions
Pharma
Market Research
Institutions
Support
Support Center
Install
My Account
Stay Connected
Facebook
Twitter
YouTube